Finsbury Glover Hering and Sard Verbinnen & Co to Merge, Creating Global Strategic Communications Leader
13.10.2021 07:00:00 EEST | Business Wire | Press release
Finsbury Glover Hering and Sard Verbinnen & Co (“SVC”) today announced a merger to create the world’s leading strategic communications firm advising clients in navigating critical opportunities and challenges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211012006255/en/
The new firm will help clients achieve their missions and realize their business goals, with approximately 1,000 professionals operating from 25 offices in Asia, Europe, the Middle East and the United States, including its global headquarters in New York. Pro forma combined 2020 revenue was more than $330 million.
Over the past three decades, both firms have built impressive reputations advising clients during their most significant transformational events. The new firm will be a leader in all aspects of strategic communications, including government affairs, corporate reputation, crisis management and transformation and change, as well as the leading force in financial communications worldwide, with strong experience and expertise in M&A, private equity, IPOs, SPAC transactions, shareholder activism and restructurings.
The combined firm will offer clients world-class expertise and counsel through five integrated offerings, supported by specialist teams providing Research and Insights, Digital Strategy and Design and Creative capabilities:
- Crisis and Issues Management, delivering sophisticated strategic thinking, candid advice and agile execution that enables clients to prepare for and manage high-stakes situations, complex issues and periods of intense scrutiny while communicating with clarity, integrity and consistency;
- Public Policy and Government Affairs, drawing upon decades of government, campaign and policy experience and strong networks in the world’s capitals to enable clients to shape the regulatory and policy debates across leading regions;
- Financial and Transaction Communications, advising on the world’s largest, most complex mergers and acquisitions, IPOs, SPAC transactions, restructurings, spin-offs and shareholder activist situations to help clients maximize their value and move decisively ahead;
- Corporate Reputation, developing strategies that position clients for success, build trust with stakeholders and meet shifting societal expectations while protecting, strengthening and repairing reputations, based on in-depth research, sound judgment and creative thinking; and
- Transformation and Change, supporting businesses and organizations at their most critical moments with internal communications that engage, empower and energize employees and other stakeholders, drive cultural change and advance business objectives.
The combined firm’s professionals have deep sector knowledge within rapidly growing industries, such as Health, Food and Agriculture and Renewable Energy, as well as expertise in Diversity, Equity and Inclusion (DE&I), Environmental, Social and Governance (ESG), litigation and regulatory communications and cybersecurity.
Senior professionals from Finsbury Glover Hering and SVC will lead the new company. George Sard will join Roland Rudd and Carter Eskew as Co-Chairmen. Alexander Geiser will serve as Global CEO; Mike Feldman and Paul Verbinnen as Co-Chairs of North America; Andrew Cole as Deputy Global CEO as well as Co-CEO of North America with Joel Johnson, Paul Kranhold and Winnie Lerner; Faeth Birch as CEO of UK, Middle East and Asia; and Brigitte von Haacke as CEO of Europe. In addition, Sanjay Bhutiani will be Global CTO, Randal Bridges will be Global CIO, Ajay Junnarkar will be Global CFO and Sydney Neuhaus will be Global COO.
Equity in the new company will be owned by nearly 40 percent of the firm’s employees. WPP will remain the majority investor. Golden Gate Capital, which is a significant minority investor in SVC, will convert its equity in SVC and remain an investor in the new firm.
Finsbury Glover Hering Global Co-Chairmen Roland Rudd and Carter Eskew said: “Our clients operate in an increasingly complex world with diverse stakeholder interests. To generate growth, open markets, shape policy and attract capital, companies need to seamlessly communicate to more audiences and across more markets than ever before. This merger brings together the most accomplished communications professionals, operating within a global firm that will have the expertise and experience to deliver reputation advisory services to address critical c-suite concerns.”
SVC Co-Founders George Sard and Paul Verbinnen added: “This is a combination of two successful, growing firms with strong track records, complementary leadership positions, deep entrepreneurial spirits, cultures of collaboration and integrity and a heritage of delivering for our clients at their most high-pressure moments. Our success has been driven by our teams’ tireless commitment to supporting our clients and one another and upholding high standards of excellence in all that we do. We are particularly excited that the combination will enable us to provide additional professional development opportunities and establish a new generation of employee owners in the combined company.”
Mark Read, CEO of WPP, said: “The demand for Board-level strategic advice on a growing range of financial, reputational and social issues has never been greater. As the reputations of companies and their brands become ever more closely linked, our leadership in this area is a core part of our offer as we support our clients’ continued transformation. WPP is delighted to support the ambitions of the leadership teams of Finsbury Glover Hering and SVC in creating a powerhouse in strategic communications, with the expertise, scale and footprint to provide unparalleled service to global clients.”
Neale Attenborough, an Operating Partner at Golden Gate Capital said: “We have a strong partnership with George, Paul and the entire SVC leadership team and have enjoyed seeing their business grow rapidly over the past five years. We are very excited about this partnership, especially as it creates the pre-eminent firm in the strategic communications sector. Golden Gate Capital will remain an investor in the combined company.”
The merger is expected to be completed in Q4 2021 and the combined company will operate under a new name starting in 2022. Financial terms of the transaction were not disclosed.
Notes to Editors
SVC has for many years been the top global transaction communications advisor on M&A, IPOs and SPACs – consistently ranked as a leader in the North America and global M&A league tables. SVC is also a leader in advising companies facing shareholder activist campaigns, a leading firm in litigation and crisis communications and has advised on many high-stakes situations around the world with particular areas of strength in the U.S. and Asia. Headquartered in New York, SVC has broad capabilities across the U.S., with strong teams in offices in San Francisco, Los Angeles, Chicago, Houston, Washington D.C. and Boston, as well as in London and Hong Kong. A South Florida office will open shortly.
Finsbury Glover Hering is a global strategic communications advisory firm, headquartered in New York with over 800 multidisciplinary experts across the world’s major financial, government, business and cultural centers. Finsbury Glover Hering is a leader in crisis, corporate reputation, public affairs and capital markets and M&A advisory, as well as an acknowledged leader in boardroom communication counsel. The company was formed through the merger of leading strategic communications consultancies Finsbury, The Glover Park Group and Hering Schuppener in January 2021. Finsbury Glover Hering serves its global client base from offices in Abu Dhabi, Beijing, Berlin, Brussels, Dubai, Dublin, Düsseldorf, Frankfurt, Hong Kong, London, Los Angeles, Munich, New York, Paris, Riyadh, Shanghai, Singapore, Tokyo, Washington D.C. and Zurich.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211012006255/en/
Contact information
Press
Dorothy Burwell
Finsbury Glover Hering
dorothy@fgh.com
+44 7733 294 930
Anna Cordasco / Brooke Gordon
Sard Verbinnen & Co
cordasco@sardverb.com / bgordon@sardverb.com
212-687-8080
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 12:52:00 EEST | Press release
The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not merely a wage dispute. It stems from deep structural concerns regarding the company’s ESG management, lack of operational autonomy, and passive labor relations. Primarily, the union highlighted unresolved corporate governance issues, including allegations concerning unfair labor practices and the unauthorized use of employee personal data, which were prominently reported by South Korea's major broadcaster, MBC, in November 2025. The union believes this crisis stems from management's failure to address r
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
